151 related articles for article (PubMed ID: 7382975)
21. [Clinical experience with sulprostone (author's transl)].
Brabec W; Dapunt O; Bichler A
Wien Klin Wochenschr; 1981 Mar; 93(6):193-7. PubMed ID: 7281695
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin F2 alpha for interrupting pregnancy, managing intrauterine death and molar pregnancy and inducing labor.
de Gezelle H; Thiery M; Parewijck W; Decoster JM
Int J Gynaecol Obstet; 1980; 17(4):362-7. PubMed ID: 6102058
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of extra-amniotic prostaglandin F2 alpha infusion and increasing intravenous oxytocin for termination of second trimester missed abortion.
Jaschevatzky OE; Rosenberg RP; Noy Y; Dascalu S; Anderman S; Ballas S
J Am Coll Surg; 1994 May; 178(5):435-8. PubMed ID: 8167879
[TBL] [Abstract][Full Text] [Related]
24. Treatment of missed abortion and hydatidiform mole by high-concentration oxytocin infusion.
TOAFF R; AYALON D
Obstet Gynecol; 1962 Jan; 19():81-6. PubMed ID: 13921449
[No Abstract] [Full Text] [Related]
25. Simultaneous intravenous infusion of prostaglandin E2 (PGE2) and oxytocin in the management of intrauterine death of the fetus, missed abortion and hydatidiform mole.
Naismith WC; Barr W
J Obstet Gynaecol Br Commonw; 1974 Feb; 81(2):146-9. PubMed ID: 4816026
[No Abstract] [Full Text] [Related]
26. [Transcervical intra-amniotic induction with PgF2 alpha in missed abortion and labor in the 3d trimester of pregnancy with dead fetus. II].
Rizzuto E; Ferraro I
Minerva Ginecol; 1985 Apr; 37(4):137-9. PubMed ID: 3861959
[No Abstract] [Full Text] [Related]
27. Extra-amniotic prostaglandin E2 for midtrimester termination of pregnancy in live fetuses vs. fetal demise.
Debby A; Sagiv R; Girtler O; Sadan O; Glezerman M; Golan A
Arch Gynecol Obstet; 2003 Oct; 268(4):301-3. PubMed ID: 14504874
[TBL] [Abstract][Full Text] [Related]
28. [Results of pregnancy termination for foetal congenital or chromosomal disorders or intrauterine foetal death by oral mifepristone and/or intravaginal misoprostol; results of a retrospective study].
Verhulsdonk MT; Papatsonis DN; Heydanus R
Ned Tijdschr Geneeskd; 2007 Apr; 151(14):815-20. PubMed ID: 17469323
[TBL] [Abstract][Full Text] [Related]
29. [Extraamniotic induction of abortion with a new prostaglandin E-2 derivative].
Gethmann U; Schuster E; Hoppen HO; Oberheuser F
Fortschr Med; 1978 Sep; 96(35):1771-3. PubMed ID: 738690
[TBL] [Abstract][Full Text] [Related]
30. Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
Lebed JP; Rubin A; Millman AE
Obstet Gynecol; 1980 Jul; 56(1):90-6. PubMed ID: 7383493
[TBL] [Abstract][Full Text] [Related]
31. [Monitoring of the induction of labour by prostaglandin f2alpha in early pregnancy (author's transl)].
Wiechell H; Massenbach W
Geburtshilfe Frauenheilkd; 1974 Sep; 34(9):767-75. PubMed ID: 4437567
[TBL] [Abstract][Full Text] [Related]
32. Use of prostaglandin E2 in the management of missed abortion, missed labour, and hydatidiform mole.
Karim SM
Br Med J; 1970 Jul; 3(5716):196-7. PubMed ID: 5448780
[TBL] [Abstract][Full Text] [Related]
33. [Termination of pregnancy with 16,16-dimethyl-trans-delta2 PGE1 methyl ester vaginal suppositories: an analysis of 182 cases].
Du MK; Ying YD; Zheng HM; Yuan YE; Zhu Y
Shengzhi Yu Biyun; 1982 Jun; 2(2):28-31. PubMed ID: 12279680
[TBL] [Abstract][Full Text] [Related]
34. [Use of prostaglandins for termination of pregnancy in case of hydatidiform mole, missed abortion and anencephaly].
Thiery M; De Hemptinne D; Yo Le Sian A; Amy JJ
Tijdschr Geneeskd; 1975 May; 9(31):441-7. PubMed ID: 12336443
[TBL] [Abstract][Full Text] [Related]
35. Rupture of the uterus after midtrimester prostaglandin abortion.
Cederqvist LL; Birnbaum SJ
J Reprod Med; 1980 Sep; 25(3):136-8. PubMed ID: 7431358
[TBL] [Abstract][Full Text] [Related]
36. [Clinico-experimental results of the use of alpha F2 prostaglandin in some obstetrical physiopathological conditions].
Proto M; Casati G
Minerva Ginecol; 1975 Jul; 27(7):523-36. PubMed ID: 1207954
[No Abstract] [Full Text] [Related]
37. Cesarean section on request at 39 weeks: impact on shoulder dystocia, fetal trauma, neonatal encephalopathy, and intrauterine fetal demise.
Hankins GD; Clark SM; Munn MB
Semin Perinatol; 2006 Oct; 30(5):276-87. PubMed ID: 17011400
[TBL] [Abstract][Full Text] [Related]
38. A clinical trial of induction of labor versus expectant management in postterm pregnancy. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Am J Obstet Gynecol; 1994 Mar; 170(3):716-23. PubMed ID: 7710467
[TBL] [Abstract][Full Text] [Related]
39. The use of prostaglandins for termination of abnormal pregnancy.
Christensen NJ; Bygdeman M
Acta Obstet Gynecol Scand Suppl; 1983; 113():153-7. PubMed ID: 6574672
[TBL] [Abstract][Full Text] [Related]
40. [Use of a prostaglandin (PGF2 alpha--Prostin 15M) in the induction of labor in fetal death--missed labor].
Berić BM; Marjanović M; Aleksić S; Belopavlović Z; Ancić V
Med Pregl; 1986; 39(3-4):111-3. PubMed ID: 3464820
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
